{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:44:21Z","timestamp":1791290661531,"version":"4.3.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.pbb.2014.05.006","type":"journal-article","created":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T05:02:22Z","timestamp":1400130142000},"page":"5-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"special_numbering":"C","title":["Valsartan reverses depressive\/anxiety-like behavior and induces hippocampal neurogenesis and expression of BDNF protein in unpredictable chronic mild stress mice"],"prefix":"10.1016","volume":"124","author":[{"given":"Gu","family":"Ping","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Zhaochun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2014.05.006_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/mp.2008.119","article-title":"The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling","volume":"14","author":"Bessa","year":"2009","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pbb.2014.05.006_bb0010","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0166-4328(01)00349-7","article-title":"AT (2) but not AT (1) receptor antagonism abolishes angiotensin II increase of the acquisition of conditioned avoidance responses in rats","volume":"131","author":"Braszko","year":"2002","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2014.05.006_bb0015","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/10641960500298723","article-title":"Valsartan abolishes most of the memory-improving effects of intracerebroventricular angiotensin II in rats","volume":"27","author":"Braszko","year":"2005","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.pbb.2014.05.006_bb0020","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1385\/MN:29:3:289","article-title":"Neurotrophins as mediators of drug effects on mood, addiction, and neuroprotection","volume":"29","author":"Castren","year":"2004","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.pbb.2014.05.006_bb0025","doi-asserted-by":"crossref","first-page":"12796","DOI":"10.1073\/pnas.211427898","article-title":"Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine","volume":"98","author":"Czeh","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pbb.2014.05.006_bb0030","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.neuron.2009.04.017","article-title":"Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety\/depression","volume":"62","author":"David","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.pbb.2014.05.006_bb0035","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/hipo.20410","article-title":"Dynamic expression of TrkB receptor protein on proliferating and maturing cells in the adult mouse dentate gyrus","volume":"18","author":"Donovan","year":"2008","journal-title":"Hippocampus"},{"key":"10.1016\/j.pbb.2014.05.006_bb0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1517\/14728222.8.1.7","article-title":"Angiotensin as a target for the treatment of Alzheimer's disease, anxiety and depression","volume":"8","author":"Gard","year":"2004","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.pbb.2014.05.006_bb0045","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1161\/01.CIR.100.6.685","article-title":"Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension","volume":"100","author":"Gottdiener","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pbb.2014.05.006_bb0050","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1006\/phrs.1997.0239","article-title":"Losartan influences behavioural effects of angiotensin II(3-7) in rats","volume":"36","author":"Karwowska-Polecka","year":"1997","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pbb.2014.05.006_bb0055","first-page":"1","article-title":"Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis","author":"Kreisel","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pbb.2014.05.006_bb0060","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejphar.2009.11.036","article-title":"Impaired spatial working memory and decreased frontal cortex BDNF protein level in dopamine transporter knockout mice","volume":"628","author":"Li","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2014.05.006_bb0065","first-page":"28","article-title":"The link between angiotensin II-mediated anxiety and mood disorders with NADPH oxidase-induced oxidative stress","volume":"4","author":"Liu","year":"2012","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"10.1016\/j.pbb.2014.05.006_bb0070","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S1734-1140(12)70730-2","article-title":"Anxiolytic-like effect of losartan injected into amygdala of the acutely stressed rats","volume":"64","author":"Llano Lopez","year":"2012","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pbb.2014.05.006_bb0075","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1527-3458.2008.00040.x","article-title":"Therapeutic potential of fluoxetine in neurological disorders","volume":"14","author":"Mostert","year":"2008","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.pbb.2014.05.006_bb0080","first-page":"365","article-title":"Valsartan inhibits angiotensin II-stimulated proliferation of smooth muscle cells from human coronary artery","volume":"37","author":"Mueck","year":"1999","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.pbb.2014.05.006_bb0085","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1523\/JNEUROSCI.16-07-02365.1996","article-title":"Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus","volume":"16","author":"Nibuya","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.pbb.2014.05.006_bb0095","doi-asserted-by":"crossref","unstructured":"Nollet, M, Gaillard, P, Tanti, A, Girault, V, Belzung, C, Leman, S. Neurogenesis-independent antidepressant-like effects on behavior and stress axis response of a dual orexin receptor antagonist in a rodent model of depression. Neuropsychopharmacology; 37: 2210-2221.","DOI":"10.1038\/npp.2012.70"},{"key":"10.1016\/j.pbb.2014.05.006_bb0090","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.neuropharm.2011.04.022","article-title":"Activation of orexin neurons in dorsomedial\/perifornical hypothalamus and antidepressant reversal in a rodent model of depression","volume":"61","author":"Nollet","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2014.05.006_bb0100","doi-asserted-by":"crossref","first-page":"e17600","DOI":"10.1371\/journal.pone.0017600","article-title":"Necessity of hippocampal neurogenesis for the therapeutic action of antidepressants in adult nonhuman primates","volume":"6","author":"Perera","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pbb.2014.05.006_bb0105","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1080\/08870446.2013.795223","article-title":"Coping strategies, depressive symptoms and quality of life in hypertensive patients: mediational and prospective relations","volume":"28","author":"Rueda","year":"2013","journal-title":"Psychol Health"},{"key":"10.1016\/j.pbb.2014.05.006_bb0110","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.1083328","article-title":"Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants","volume":"301","author":"Santarelli","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.pbb.2014.05.006_bb0115","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0006-8993(98)01010-5","article-title":"Downregulation of BDNF mRNA and protein in the rat hippocampus by corticosterone","volume":"813","author":"Schaaf","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2014.05.006_bb0120","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1192\/bjp.172.6.527","article-title":"Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study","volume":"172","author":"Shah","year":"1998","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pbb.2014.05.006_bb0125","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/npp.2008.90","article-title":"Abstinence following alcohol drinking produces depression-like behavior and reduced hippocampal neurogenesis in mice","volume":"34","author":"Stevenson","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2014.05.006_bb0130","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.biopsych.2008.02.022","article-title":"Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal","volume":"64","author":"Surget","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2014.05.006_bb0135","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/mp.2011.48","article-title":"Antidepressants recruit new neurons to improve stress response regulation","volume":"16","author":"Surget","year":"2011","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pbb.2014.05.006_bb0140","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1172\/JCI31547","article-title":"Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease","volume":"117","author":"Wang","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pbb.2014.05.006_bb0145","doi-asserted-by":"crossref","first-page":"2321.e1","DOI":"10.1016\/j.neurobiolaging.2010.05.004","article-title":"Carvedilol as a potential novel agent for the treatment of Alzheimer's disease","volume":"32","author":"Wang","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pbb.2014.05.006_bb0150","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3233\/JAD-2012-120904","article-title":"Investigation of nebivolol as a novel therapeutic agent for the treatment of Alzheimer's disease","volume":"33","author":"Wang","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.pbb.2014.05.006_bb0155","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/hipo.20156","article-title":"Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment","volume":"16","author":"Warner-Schmidt","year":"2006","journal-title":"Hippocampus"},{"key":"10.1016\/j.pbb.2014.05.006_bb0160","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s002130050456","article-title":"Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation","volume":"134","author":"Willner","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.pbb.2014.05.006_bb0165","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jad.2013.05.008","article-title":"Recurrent depression, cardiovascular disease, and diabetes among middle-aged and older adult women","volume":"150","author":"Windle","year":"2013","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pbb.2014.05.006_bb0170","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/35072566","article-title":"Research and treatment approaches to depression","volume":"2","author":"Wong","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pbb.2014.05.006_bb0175","first-page":"630","article-title":"Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 5th communication: hemodynamic effects of valsartan in dog heart failure models","volume":"47","author":"Yamamoto","year":"1997","journal-title":"Arzneimittelforschung"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305714001403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305714001403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T09:36:46Z","timestamp":1565429806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305714001403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":35,"alternative-id":["S0091305714001403"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2014.05.006","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valsartan reverses depressive\/anxiety-like behavior and induces hippocampal neurogenesis and expression of BDNF protein in unpredictable chronic mild stress mice","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2014.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}